Wearable cardiac devices market seen reaching $13.42 billion by 2030

The wearable cardiac devices market is projected to grow from $5.65 billion in 2025 to $6.73 billion in 2026, then rise to $13.42 billion by 2030, according to The Business Research Company. Growth is being driven by rising cardiovascular disease rates, sensor miniaturization, remote monitoring, and broader smartphone integration.

Why it matters: - Wearable cardiac devices are becoming a key tool for continuous heart monitoring outside hospitals. - The market’s projected climb to $13.42 billion by 2030 signals stronger adoption by patients, providers and health systems. - Rising cardiovascular disease cases are increasing demand for earlier detection and ongoing management.

What happened: - The Business Research Company released its Wearable Cardiac Devices Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035. - The report puts the market at $5.65 billion in 2025 and $6.73 billion in 2026. - The report forecasts the market will reach $13.42 billion by 2030. - The report estimates a 19.1% CAGR from 2025 to 2026 and an 18.8% CAGR through 2030. - The report says North America was the largest regional market in 2025. - The report says Asia-Pacific is expected to grow fastest over the coming years.

The details: - Wearable cardiac devices use built-in sensors to continuously track heart rate and rhythm. - The devices can detect abnormal rhythms and, in some cases, deliver therapeutic electrical shocks to restore a healthy heartbeat. - The report points to sensor miniaturization as a major technology trend. - Remote patient monitoring is expanding as smartphone integrations make data sharing easier for patients and healthcare providers. - Wearable defibrillators are gaining popularity as tools intended to prevent sudden cardiac arrest. - Fitness and wellness devices that also track heart health are drawing more consumer interest. - Wireless and disposable cardiac patches are adding to product diversity in the category. - Historical growth was held back by limited access to advanced cardiac monitoring, high early device prices, hospital-centered monitoring models and low consumer awareness. - Future growth is expected from broader reimbursement policies, more remote monitoring, smartphone and digital health integration, and higher health awareness. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report’s 2026 edition includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables. - A free sample is available here. - The full report is available here.

Between the lines: - The fastest growth appears tied to devices that fit into everyday consumer behavior, not just clinical workflows. - Smartphone-connected monitoring and patch-based devices suggest the category is moving toward simpler, lower-friction use. - The public health case is strong: the CDC said cardiovascular disease caused 919,032 U.S. deaths in 2023, or one in every three deaths. - The CDC also said about one in six cardiovascular deaths occurred in adults younger than 65, underscoring the appeal of earlier monitoring.

What's next: - Broader reimbursement and continued sensor advances could widen access to wearable cardiac devices. - Asia-Pacific’s faster growth rate may shift more commercial attention to that region. - Continued integration with remote patient monitoring platforms is likely to shape product development and adoption. - The company is offering expert contact channels and social media links for more information, including LinkedIn, Facebook and X.